Want to see HK:1276 full AI Analyst Report?

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Revenue

9 Followers

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Revenue

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H had a revenue of 8.42B in the quarter ending Jun 30, 2026, with -9.15%. This bring the company's revenue in the last twelve months to 35.06B, Increased -2.26%. In the fiscal year ending Dec 31, 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H had annual revenue of 35.19B with 18.20% growth.

Revenue (ttm)

35.06B

Revenue Growth

7.52%

P/S Ratio

10.32

Revenue/Employee

HK$1,707,976

Employees

20,602

Market Cap

HK$362.98B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	35.19B	5.42B	+18.20%
Dec 31, 2024	29.77B	4.51B	+17.87%
Mar 31, 2024	25.26B	1.03B	+4.24%
Mar 31, 2023	24.23B	-6.79B	-21.89%
Mar 31, 2022	31.02B	108.55M	+0.35%
Dec 31, 2020	30.91B	4.72B	+18.00%
Dec 31, 2019	26.20B	5.82B	+28.54%
Dec 31, 2018	20.38B	4.69B	+29.93%
Dec 31, 2017	15.69B	―	―